We reason that guided enrollment of patients (e.g., selection of patients with the aberrantly active JAK-STAT pathway in tumor cells), rational scheduling of JAK-STAT inhibitors with RT [65], as well as RT dose and fractionation (single high-dose RT may not be ideal [84,151]). Here, SOAT1 is linked to neoplasm.